The present invention relates to a conjugate comprising (i) a cell binding agent that binds to a human mucin-1 glycoprotein (MUC1), linked (ii) with at least one cytotoxic agent, for use in the treatment of cancer, wherein said conjugate is administered at a dose of at least 120 mg / m.
展开▼
机译：本发明涉及缀合物，其用于治疗癌症，所述缀合物包含（i）与人粘蛋白-1糖蛋白（MUC1）结合的细胞结合剂，所述细胞结合剂与至少一种细胞毒性剂连接（ii）。以至少120mg / m 2的剂量施用。
展开▼
